drug

KSQ-004

Phase 2updated 3mo ago

by KSQ Therapeutics Inc

Phase 2

community read0 votes

indications

NSCLCColorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying KSQ-004

phase2A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumorsrecruitingn=141

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 45m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

KSQ-004

Phase 2updated 3mo ago

by KSQ Therapeutics Inc

Phase 2

community read0 votes

indications

NSCLCColorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying KSQ-004

phase2A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumorsrecruitingn=141

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 45m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

KSQ-004

indications

all catalysts(0)

Trials studying KSQ-004

News(0)

Report a data issue

comments(0)

KSQ-004

indications

all catalysts(0)

Trials studying KSQ-004

News(0)

Report a data issue

comments(0)